Resorbable Vascular Scaffold Market Trends Analysis, Growth Opportunities and Challenges, Clinical Activities, Leading Companies, Emerging Therapies, and Epidemiology Forecast

The  Resorbable Vascular Scaffold Market report from DelveInsight provides an in-depth analysis of  Resorbable Vascular Scaffold, as well as historical and forecasted market trends in the 7MM (the US, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Some Key Highlights from the  Resorbable Vascular Scaffold Market Report

  • The drawbacks of metallic stents, such as vascular caging with reduced coronary vasomotion and the impossibility of bypass operations in stented segments, were addressed by the development of Resorbable scaffolds (RS).

  • Resorbable Vascular Scaffold market is segmented on the basis of Product Type, By Applications, and End-user.
  • Some of the  Resorbable Vascular Scaffold available in the market include balloon-expandable Absorb  (Abbott Medical Devices), HeartWare® VAS (Medtronic), LVAD implant (Inova Health Care Services), and others.
  • Major players which are active in the  Resorbable Vascular Scaffold market include – Abiomed, Inc., Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.), Abbott Laboratories (St. Jude Medical, Inc.), Berlin Heart GmbH, Jarvik Heart, Inc., Medtronic Plc., Terumo Corporation, Evaheart, Inc., Calon Cardio, SynCardia Systems LLC

Request sample @Resorbable Vascular Scaffold Market Insights

The market report on  Resorbable Vascular Scaffold includes an overview of the industry as well as a PEST Analysis. The report also examines market drivers, market constraints, and unmet medical needs in order to identify the greatest prospects and analyze the market’s underlying potential.

Resorbable Vascular Scaffold Overview

The drawbacks of metallic drug-eluting stents, which permanently cage the arterial wall and hinder normal coronary vasomotion, preclude bypass grafting, and can cause long-lasting foreign-body reactions, were addressed by the development of fully resorbable scaffolds (RS).

The Absorb Bioresorbable Vascular Scaffold (BVS; Abbott Vascular), though many scaffolds have been or are in development, was the first FDA-approved device and was widely anticipated to fulfil interventional cardiologists’ hopes for a transient scaffold that would disappear “when the job was done” and would not restrict further treatment options.

 Resorbable Vascular Scaffold Market

The Resorbable Vascular Scaffolds market report provides an overview of Resorbable Vascular Scaffolds, applications of Resorbable Vascular Scaffolds as well as its advantages and limitations. Additionally, the report provides insight on the Resorbable Vascular Scaffolds market share by segments, along with an assessment of market share by regions, the qualitative and quantitative (USD million, 2019-2027) data will be provided for all the segments in the scope. 

The market is broad, with a large variety of products accessible, and key companies such as Abbott Laboratories, St. Jude Medical, Inc., and Berlin Heart GmbH, among others, are present.

Know more about medical devices @Resorbable Vascular Scaffold Market Outlook

 Resorbable Vascular Scaffold Key Companies

  • Abbott
  • Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.) 
  • Abbott Laboratories (St. Jude Medical, Inc.) 
  • Berlin Heart GmbH 
  • Jarvik Heart, Inc. 
  • Medtronic Plc. 
  • Terumo Corporation 
  • Evaheart, Inc. 
  • Calon Cardio 
  • SynCardia Systems LLC, and others.

 Resorbable Vascular Scaffold Market Drivers

  • Growing number of surgeries
  • Increasing cardiovascular disease population
  • Technological advancements in product development

 Resorbable Vascular Scaffold Market Barriers

  • High product pricing
  • Stringent Regulatory Process

 Resorbable Vascular Scaffold Unmet Needs

Lengthy product approval process

Get more insights @Resorbable Vascular Scaffold Major Players

Scope for the Report

Coverage: 7MM (the US, EU5 (the UK, Germany, Italy, Spain, and France) and Japan)

Study Period: 2019-27

Resorbable Vascular Scaffold Key Companies:  Abiomed, Inc., Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.), Abbott Laboratories (St. Jude Medical, Inc.), Berlin Heart GmbH, Jarvik Heart, Inc., Medtronic Plc., Terumo Corporation, Evaheart, Inc., Calon Cardio, SynCardia Systems LLC, among others. 

Tools Used: PEST Analysis

KOL’s Views

Table of Contents 

1. Key Insights
2. Executive Summary of  Resorbable Vascular Scaffold 
3. Resorbable Vascular Scaffold: Background and Overview
4. Resorbable Vascular Scaffold: Regulatory Framework
5. Resorbable Vascular Scaffold: Reimbursement Scenario
6. Company Profiles
7. Resorbable Vascular Scaffold: Competitive Analysis of Listed Products
8. Resorbable Vascular Scaffold: KOL Views
9. Resorbable Vascular Scaffold: Market Analysis in 7MM
10. Country-Wise Market size of  Resorbable Vascular Scaffold   in 7MM
11. Market Dynamics
12. PEST Analysis
13. Conclusion and Future perspective
14. Appendix
15. DelveInsight Capabilities
16. Disclaimer
17. About DelveInsight

Know more about report offerings @Resorbable Vascular Scaffold Market

Related Reports

Diagnostic Imaging Equipment Market

Diagnostic Imaging Equipment Market By Product (X-Ray Imaging Systems, Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Nuclear Imaging Systems, Mammography Systems, And Others), By Application (Cardiology, Oncology, Gastroenterology, Gynecology, And Other Applications), By End-User (Hospitals, Diagnostic Imaging Centres, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancement and increasing prevalence of chronic diseases.

Invasive Candidiasis Market

“DelveInsight’s ‘Invasive Candidiasis Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Invasive Candidiasis and the historical and forecasted Invasive Candidiasis market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Sialidosis Market 

DelveInsight’s “Sialidosis Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Sialidosis, historical and forecasted epidemiology as well as the Sialidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Filgrastim Biosimilar Insight

DelveInsight’s, “Filgrastim Biosimilar Insight, 2022,” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in the Filgrastim Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. 

Resorbable Vascular Scaffold Market

Resorbable Vascular Scaffold Market By Type Of Devices (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices And Cryoablation Devices], And Others), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), By Geography is expected to grow at a steady CAGR Forecast till 2027 

Latest Reports by DelveInsight

Basal Cell Carcinoma Market | Birch Allergy Market | Bile Duct Neoplasm Market | Gingivitis MarketLupus Nephritis Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Congestive Heart Failure Market | Gingivitis Market | Lupus Nephritis Market | Erythromelalgia Market | AL Amyloidosis Market | Primordial Dwarfism Market | Breast Pumps Market | Hyperuricemia Market | Helicobacter Pylori (H. pylori) Infection Market | AIDS Dementia- Market | Follicular Lymphoma Market | Chronic Pulmonary Hypertension Market | Adrenal Crisis Market | Retinoblastoma Market | Non-Cystic Fibrosis Bronchiectasis Market | Microsatellite Stable Colorectal Cancer Market | Chondrosarcoma Market | Sialidosis Market

For more detailed information visit: https://www.delveinsight.com/eular-conference/eular-2022

 

To know more about our Competitive Services, Click here: Pharma Competitive Intelligence

https://www.delveinsight.com/consulting/competitive-intelligence-services

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance. 

Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Contact Us 

Gaurav Bora

[email protected] 

+1(919)321-6187 

www.delveinsight.com

Connect With Us at:

LinkedIn | Facebook | Twitter

Posted on

Leave a Reply

Your email address will not be published.